| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |